Exponent, Inc. (NASDAQ:EXPO – Free Report) – Analysts at William Blair cut their Q1 2025 earnings per share estimates for shares of Exponent in a research note issued on Friday, February 7th. William Blair analyst A. Nicholas now anticipates that the business services provider will post earnings of $0.48 per share for the quarter, down from their prior estimate of $0.56. The consensus estimate for Exponent’s current full-year earnings is $2.11 per share. William Blair also issued estimates for Exponent’s Q4 2025 earnings at $0.43 EPS, Q1 2026 earnings at $0.53 EPS, Q2 2026 earnings at $0.60 EPS, Q3 2026 earnings at $0.58 EPS, Q4 2026 earnings at $0.48 EPS and FY2026 earnings at $2.19 EPS.
Exponent Stock Performance
NASDAQ EXPO opened at $91.01 on Monday. Exponent has a fifty-two week low of $74.30 and a fifty-two week high of $115.75. The stock has a market cap of $4.62 billion, a PE ratio of 42.93 and a beta of 0.71. The firm’s fifty day moving average price is $91.68 and its two-hundred day moving average price is $100.45.
Exponent Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Friday, March 7th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.32%. This is a positive change from Exponent’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, March 7th. Exponent’s dividend payout ratio (DPR) is presently 52.83%.
Insiders Place Their Bets
In related news, Director Paul R. Johnston sold 1,300 shares of the business’s stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $95.03, for a total value of $123,539.00. Following the transaction, the director now owns 59,406 shares in the company, valued at $5,645,352.18. The trade was a 2.14 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 2.10% of the company’s stock.
Institutional Investors Weigh In On Exponent
Several large investors have recently added to or reduced their stakes in the business. Barclays PLC grew its stake in shares of Exponent by 219.0% in the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after buying an additional 66,263 shares during the period. Geneva Capital Management LLC increased its holdings in shares of Exponent by 1.7% during the third quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after acquiring an additional 27,339 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Exponent by 63.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after purchasing an additional 245,086 shares in the last quarter. Argent Capital Management LLC raised its holdings in Exponent by 17.3% during the fourth quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider’s stock worth $2,524,000 after buying an additional 4,173 shares during the last quarter. Finally, Citigroup Inc. lifted its stake in shares of Exponent by 174.7% in the third quarter. Citigroup Inc. now owns 48,309 shares of the business services provider’s stock valued at $5,569,000 after buying an additional 30,723 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- The 3 Best Retail Stocks to Shop for in August
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Investing In Preferred Stock vs. Common Stock
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.